Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary pharmacology

P J Hornby1, T P Abrahams

  • 1Department of Pharmacology LSUMC, New Orleans 70112, USA.

Clinical Obstetrics and Gynecology
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

This review covers respiratory drug safety for pregnant and nursing individuals, focusing on COPD, asthma, and upper respiratory conditions. It guides clinicians in choosing optimal therapies to ensure the best outcomes for both mother and fetus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo.

Neurogastroenterology and motility·2017
Same author

Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.

American journal of physiology. Gastrointestinal and liver physiology·2012
Same author

Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist.

British journal of pharmacology·2012
Same author

Prokineticin-1 evokes secretory and contractile activity in rat small intestine.

Neurogastroenterology and motility·2009
Same author

Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis.

Neurogastroenterology and motility·2007
Same author

Designing Spiegelmers to antagonise ghrelin.

Gut·2006
Same journal

Obstetric Care for Patients With Cognitive Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

Clinical obstetrics and gynecology·2026
Same journal

Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

Clinical obstetrics and gynecology·2026
Same journal

Menstrual Management and Contraception for Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

Clinical obstetrics and gynecology·2026
See all related articles

Area of Science:

  • Pharmacology
  • Toxicology
  • Maternal-Fetal Medicine

Background:

  • Respiratory diseases pose unique challenges during pregnancy and nursing.
  • Optimizing maternal respiratory health is crucial for fetal well-being.
  • Understanding drug pharmacodynamics and pharmacokinetics is essential for safe treatment.

Purpose of the Study:

  • To review the safety of common respiratory drugs during pregnancy and nursing.
  • To provide pharmacologic and toxicologic information for clinical decision-making.
  • To guide the selection of respiratory therapies ensuring optimal maternal and fetal outcomes.

Main Methods:

  • Review of pharmacodynamics and pharmacokinetics of respiratory medications.
  • Analysis of scientific evidence regarding the safety of COPD and asthma medications during pregnancy.

Related Experiment Videos

  • Evaluation of drug classes for upper respiratory diseases and their safety profiles in pregnant patients.

    • Main Results:

    • Inhaled bronchodilators and anti-inflammatories for asthma/COPD generally lead to lower fetal exposure.
    • Oral medications may be necessary but require careful risk-benefit assessment due to systemic levels.
    • Pseudoephedrine is favored for pregnant patients needing decongestants; intranasal corticosteroids are useful for allergic rhinitis.

    Conclusions:

    • Clinicians must weigh maternal-fetal risks when selecting respiratory medications.
    • Informed decisions on respiratory drug therapy are critical for optimal maternal and fetal health.
    • This review provides essential data for managing respiratory conditions in pregnant and nursing individuals.